Montelukast Torrent Pharma (Uk)

Montelukast, the active ingredient in Montelukast Torrent Pharma, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is used to manage asthma and allergic rhinitis in adults and children as prescribed by a healthcare professional.

GNH USA supplies Montelukast Torrent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast acts on the leukotriene pathway to control inflammatory airway diseases. - Asthma: improves chronic control and reduces exacerbations. - Allergic rhinitis: relieves nasal congestion, sneezing and itching. - Exercise‑induced bronchoconstriction: prevents airway narrowing triggered by physical activity.

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain in the head. - Abdominal pain: discomfort or cramps in the stomach area. - Cough: occasional dry or productive cough. - Fever: transient elevation of body temperature. - Sore throat: irritation or pain in the throat. - Nasopharyngitis: inflammation of the nasal passages and throat.

Serious or Rare Side Effects: - Neuropsychiatric events: agitation, depression, suicidal thoughts. - Allergic reactions: rash, angioedema, anaphylaxis. - Hepatic enzyme elevations: increased liver function tests. - Eosinophilic granulomatosis with polyangiitis: rare vasculitic disorder. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following precautions. - Assess asthma control: ensure baseline control before adding Montelukast. - Monitor neuropsychiatric symptoms: watch for mood changes or suicidal ideation. - Use caution in hepatic impairment: dose adjustment may be required. - Avoid in patients with known hypersensitivity to Montelukast or excipients. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Montelukast may interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Phenobarbital: strong enzyme inducer that reduces Montelukast exposure. - Rifampin: induces metabolism, potentially lowering efficacy. - Carbamazepine: decreases plasma concentrations of Montelukast.

Moderate Interactions (Monitor Closely): - Fluconazole: moderate CYP3A4 inhibition may increase levels. - Erythromycin: can raise Montelukast concentrations modestly. - Warfarin: may require INR monitoring due to potential pharmacodynamic changes.